Relationships between age and prior use of HRT on vertebral fracture risk reduction with raloxifene in postmenopausal women: Results from the MORE trial.

被引:0
|
作者
Johnell, O
Kanis, JA
Sarkar, S
Wu, W
de Laet, C
Oden, A
Pavo, I
机构
[1] Universitetssjukhuset MAS, Dept Orthoped, Malmo, Sweden
[2] Univ Sheffield, Sch Med, Dept Human Metab & Clin Biochem, Sheffield S10 2RX, S Yorkshire, England
[3] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
[4] Inst Med Technol Assessment, Dept Orthoped, Rotterdam, Netherlands
[5] Lilly Area Med Ctr, Vienna, Austria
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S414 / S414
页数:1
相关论文
共 50 条
  • [1] Effects of raloxifene on the risk of vertebral fracture in postmenopausal women with and without prior use of hormone replacement therapy (HRT)
    Kulkarni, PM
    Stock, JL
    Wong, M
    Johnell, O
    [J]. BONE, 2003, 32 (05) : S211 - S211
  • [2] Effects of raloxifene on the severity of new vertebral fractures in postmenopausal women with osteoporosis: Results from the MORE trial.
    Siris, E
    Crans, G
    Sarkar, S
    Wong, M
    Harper, KD
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S291 - S291
  • [3] The effects of raloxifene on incident vertebral fractures in postmenopausal women with osteoporosis: 4-year results from the MORE Trial.
    Eastell, R
    Adachi, J
    Harper, K
    Sarkar, S
    Delmas, PD
    Ensrud, K
    Gennari, C
    Reginster, JY
    Pols, H
    Recker, R
    Harris, S
    Wu, W
    Genant, H
    Black, D
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S229 - S229
  • [4] Prevalent vertebral fracture severity predicts subsequent vertebral and nonvertebral fracture risk in postmenopausal women with osteoporosis: Results from the multiple outcomes of raloxifene evaluation (MORE) trial
    Delmas, P
    Genant, H
    Crans, G
    Siris, E
    Wong, M
    Sarkar, S
    Stock, J
    Harper, K
    Adachi, J
    [J]. OSTEOPOROSIS INTERNATIONAL, 2002, 13 (06) : 521 - 521
  • [5] Prevalent vertebral fracture severity predicts subsequent vertebral and nonvertebral fracture risk in postmenopausal women with osteoporosis: Results from the multiple outcomes of raloxifene evaluation (more) trial
    Delmas, P
    Genant, H
    Crans, G
    Siris, E
    Wong, M
    Sarkar, S
    Stock, J
    Harper, K
    Adachi, J
    [J]. OSTEOPOROSIS INTERNATIONAL, 2002, 13
  • [6] Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene -: Results from a 3-year randomized clinical trial
    Ettinger, B
    Black, DM
    Mitlak, BH
    Knickerbocker, RK
    Nickelsen, T
    Genant, HK
    Christiansen, C
    Delmas, PD
    Zanchetta, JR
    Stakkestad, J
    Glüer, CC
    Krueger, K
    Cohen, FJ
    Eckert, S
    Ensrud, KE
    Avioli, LV
    Lips, P
    Cummings, SR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (07): : 637 - 645
  • [7] Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: Four-year results from a randomized clinical trial
    Delmas, PD
    Ensrud, KE
    Adachi, JD
    Harper, KD
    Sarkar, S
    Gennari, C
    Reginster, JY
    Pols, HAP
    Recker, RR
    Harris, ST
    Wu, WT
    Genant, HK
    Black, DM
    Eastell, R
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (08): : 3609 - 3617
  • [8] Effects of raloxifene on fracture risk in postmenopausal women: The raloxifene use for the heart trial
    Ensrud, Kristine E.
    Stock, John L.
    Barrett-Connor, Elizabeth
    Grady, Deborah
    Mosca, Lori
    Khaw, Kay-Tee
    Zhao, Qingwen
    Agnusdei, Donato
    Cauley, Jane A.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 (01) : 112 - 120
  • [9] The effect of raloxifene on cardiovascular risk in osteoporotic postmenopausal women: 3-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) trial.
    Harper, KD
    Barrett-Connor, E
    Sashegyi, A
    Sarkar, S
    Krueger, KA
    Cox, DA
    Anderson, PW
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2001, 49 (04) : S5 - S6
  • [10] The effect of raloxifene on risk of breast cancer in postmenopausal women - Results from the MORE randomized trial
    Cummings, SR
    Eckert, S
    Krueger, KA
    Grady, D
    Powles, TJ
    Cauley, JA
    Norton, L
    Nickelsen, T
    Bjarnason, NH
    Morrow, M
    Lippman, ME
    Black, D
    Glusman, JE
    Costa, A
    Jordan, VC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (23): : 2189 - 2197